KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EGAIN (EGAN) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for EGAIN (EGAN) over the last 16 years, with Q3 2025 value amounting to $1000.0.

  • EGAIN's Asset Writedowns and Impairment fell 9859.15% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7000.0, marking a year-over-year decrease of 10255.47%. This contributed to the annual value of $63000.0 for FY2025, which is 3225.81% down from last year.
  • Per EGAIN's latest filing, its Asset Writedowns and Impairment stood at $1000.0 for Q3 2025, which was down 9859.15% from -$10000.0 recorded in Q1 2025.
  • EGAIN's 5-year Asset Writedowns and Impairment high stood at $116000.0 for Q1 2021, and its period low was -$162000.0 during Q3 2021.
  • Over the past 5 years, EGAIN's median Asset Writedowns and Impairment value was $72500.0 (recorded in 2022), while the average stood at $37666.7.
  • In the last 5 years, EGAIN's Asset Writedowns and Impairment skyrocketed by 118888.89% in 2021 and then plummeted by 23095.24% in 2023.
  • Quarter analysis of 5 years shows EGAIN's Asset Writedowns and Impairment stood at $85000.0 in 2021, then tumbled by 80.0% to $17000.0 in 2022, then soared by 535.29% to $108000.0 in 2023, then tumbled by 98.15% to $2000.0 in 2024, then plummeted by 50.0% to $1000.0 in 2025.
  • Its Asset Writedowns and Impairment was $1000.0 in Q3 2025, compared to -$10000.0 in Q1 2025 and $2000.0 in Q4 2024.